Connect with us

Published

on

NCDC Diminish Fears Of Covid-19 Variant XEC In Nigeria—-XEC variant was observed for potential concerns, but it does not yet pose a significant risk

TCN reports that the Nigeria Centre for Disease Control and Prevention (NCDC) has reassured Nigerians that there is no cause for alarm following reports of the SARS-CoV-2 XEC variant, a sub-lineage of the Omicron strain, circulating in parts of the world, including Australia.

Director-General of NCDC, Dr Jide Idris, explained on Sunday that the XEC variant is classified as a Variant Under Monitoring (VUM). While the variant has been detected in 43 countries across Europe, Asia, North America, and recently in Africa (Botswana), it has yet to be identified in Nigeria.

He said the XEC variant was observed for potential concerns, but it does not yet pose a significant risk. He urged Nigerians to remain calm and continue adhering to basic preventive measures.

The JN.1 variant, a closely related Omicron sub-lineage, has been present in Nigeria since January 2024 and is also dominant globally. While the XEC variant demonstrates increased transmissibility, no evidence suggests it causes more severe illness.

Dr Jide reassured Nigerians that its COVID-19 Technical Working Group is closely monitoring the situation and analysing international and domestic data.

He advised Nigerians to stay informed through official channels and avoid spreading unverified information.

He also encouraged citizens to maintain personal hygiene, practice respiratory etiquette, use masks, get vaccinated and stay vigilant.

The DG urged healthcare workers to prioritise testing for respiratory and febrile illnesses and submit positive COVID-19 samples for genomic sequencing to aid monitoring efforts.

He also urged state governments to bolster health infrastructure, including diagnostic capabilities and public awareness campaigns, to enhance overall preparedness.

0Shares
Continue Reading
Click to comment

Leave a Reply

News

Sri Lanka on Alert as Nipah Virus Cases Emerge in Eastern India

Published

on

Nipah Virus Cases Emerge in Eastern India

Sri Lanka on Alert as Nipah Virus Cases Emerge in Eastern India—-Sri Lanka has stepped up monitoring measures following reports of a Nipah virus cluster in India’s eastern state of West Bengal.

Health authorities across parts of Asia have also heightened vigilance over the emerging situation, the Daily Mirror reported.

Health officials said Sri Lanka is tracking developments at the regional level and remains in contact with international health monitoring systems.

While no cases have been reported locally, authorities have indicated that preparedness measures are in place should the situation evolve.

The alert follows confirmation by Indian authorities of at least five Nipah virus infections in West Bengal, including cases among healthcare workers.

The development has prompted several countries in the region to strengthen preventive measures, particularly at international airports.

Nipah virus is a zoonotic disease transmitted between animals and humans and, in some instances, through human-to-human contact.

It is classified as a priority pathogen by the World Health Organisation due to its epidemic potential and the severity of illness it can cause. Past outbreaks of the Nipah virus have been associated with high fatality rates, ranging from 40 per cent to 75 per cent. (Xinhua/NAN)

0Shares
Continue Reading

Health & Wellbeing

EL-LAB Limited Marks 2025 World Quality Week With innovation

Published

on

EL-LAB Limited Marks 2025 World Quality Week With innovation

EL-LAB Limited Marks 2025 World Quality Week With innovation

 

EL-LAB Medical Diagnostics and Research Centre, Nigeria’s leading ISO-certified diagnostic centre, today announced its dedication to global quality standards, marking World Quality Week 2025 with the theme “Quality: Think differently” and highlighting its ISO 15189:2022 accreditation.

The centre, which was established in 1998 (27 years ago), has provided advanced medical testing services across Lagos State and continues to contribute significantly to the development of the Nigerian health sector.

Quality: The Silent Foundation of Clinical Decisions

In a statement issued by the company, Mrs. Blessing Nwakobi, Quality Assurance Manager, emphasized that Quality Assurance is the cornerstone of reliable medical diagnosis.

“In healthcare, laboratories are the silent foundation of clinical decisions. Most medical diagnoses rely on accurate laboratory results, thereby making Quality Assurance fundamental to patient safety and clinical excellence,” Mrs. Nwakobi stated

Through the successful transition to the ISO 15189:2022 standard—the highest international benchmark for medical laboratories—EL-LAB demonstrates its unwavering commitment to excellence, impartiality, and safety. This accreditation ensures that the centre’s quality management system is not merely compliant, but a living culture of competence and continual improvement.

The system is strategically built on principles including:

Patient Centred Services
Risk-Based Thinking
Continuous Improvement

·       Staff engagement, Competence and Training

This risk-based approach ensures that all activities which pose a risk to patients are managed proactively, assuring the best possible outcomes across the entire testing process

The robust quality management strategy integrates comprehensive mechanisms to guarantee the integrity of every result. Quality assurance at EL-LAB involves the strict adherence to Standard Operating Procedures (SOPs), vigorous Internal Quality Control (IQC) checks, and mandatory validation via External Quality Assessment (EQA).

These programs ensure that every test result is accurate, reproducible, reliable, and comparable with global benchmarks, reinforcing reliability and building public trust in every report issued by the laboratory.

Addressing the 2025 Quality Week theme, “Quality: Think differently,” EL-LAB’s leadership urged healthcare professionals to challenge traditional quality approaches.

“We believe thinking differently about quality begins with one powerful shift: seeing quality not as an act, but as an attitude”. “Quality is what we do when no one is watching and it shows in how we treat our patients, our colleagues, and our work. The ISO 15189:2022 accreditation is a reminder that quality is not a destination, but a journey of continuous improvement.”

EL-LAB invites all partners, colleagues, and stakeholders in the healthcare ecosystem to join them in thinking differently, noting that the future of diagnostic excellence depends on embracing change today.

About EL-LAB Medical Diagnostics and Research Centre

Established in 1998, EL-LAB Medical Diagnostics and Research Centre is a leading ISO-certified medical laboratory providing advanced, reliable, and comprehensive diagnostic services across Nigeria. Dedicated to clinical excellence and patient safety, EL-LAB leverages state-of-the-art technology and a highly competent workforce to deliver results that form the trusted foundation of patient care.

0Shares
Continue Reading

Trending

0Shares